Department of Early Clinical Development Graduate School of Medicine,Kyoto University Hospital,Department of Early Clinical Development,Kyoto Innovation Center for Next Generation Clinical Trialsand iPS Cell Therapy (Ki-CONNECT) | 京都大学医学部附属病院次世代医療・iPS細胞治療研究センター（Ki-CONNECT）早期医療開発科大学院医学研究科早期医療開発学 | Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy（Ki-CONNECT）Department of Early Clinical Development | 京都大学医学部附属病院次世代医療・iPS細胞治療研究センター（Ki-CONNECT）早期医療開発科大学院医学研究科早期医療開発学 | Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy（Ki-CONNECT）Department of Early Clinical Development

Kyoto University

Department of Early Clinical Development Graduate School of Medicine
Kyoto University Hospital
Department of Early Clinical Development
Kyoto Innovation Center for Next Generation Clinical Trials
and iPS Cell Therapy (Ki-CONNECT)

News & Press Release

Click here for a list of past News

NEWS 2022/10/01

Kumiko Nishihara moved to Department of Clinical Research Support.
NEWS 2022/10/01

October 2022 to July 2025 We started the following clinical trial “A phase 1 first in human study evaluating safety, pharmacokinetics and efficacy of ABBV-400 in adult subjects with adult subjects with advanced solid tumors”
NEWS 2022/09/01

September 2022 to May 2025 We started the following clinical trial “A study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors”
NEWS 2022/08/01

August to December 2022 We started the following clinical trial “An Open-Label, Dose Escalation, Phase 1, First-in Human Study of TAK-102 in Adult Patients with GPC3-Expressing Previously Treated Solid Tumors”
NEWS 2022/04/19

“Study on age-related changes in human immunocompetent cells” (new research on new coronavirus vaccine) has started.